Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pacing and heart failure]

C Leclercq1, S Cazeau, P Ritter

  • 1Département de cardiologie et maladies vasculaires, CHU de Rennes.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Correction to: Asymptomatic ALCAPA with Preserved Myocardial Functionin a 3‑Year‑Old Child.

Pediatric cardiology·2025
Same author

Circadian rhythm parameters differentiate euthymic, manic and depressive mood states in bipolar disorders - an explorative pilot study.

International journal of bipolar disorders·2025
Same author

Asymptomatic ALCAPA with Preserved Myocardial Function in a 3-Year-Old Child.

Pediatric cardiology·2025
Same author

Der Nervenarzt·2025
Same author

Biologics for eosinophilic otitis media: a retrospective case study in a multidisciplinary center.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2024
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Biventricular pacing shows promise for treating refractory cardiac failure in dilated cardiomyopathy patients with conduction defects. Further randomized trials are needed to confirm its long-term effectiveness and validate this therapeutic approach.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Refractory cardiac failure is a significant challenge in dilated cardiomyopathy.
  • Conventional right ventricular apex pacing has shown limited long-term efficacy.
  • Biventricular pacing offers a potential solution for electromechanical dyssynchrony.

Purpose:

  • To evaluate the preliminary efficacy of biventricular pacing in patients with refractory cardiac failure and dilated cardiomyopathy.
  • To assess the potential of biventricular pacing in correcting intraventricular conduction defects.

Summary:

  • Biventricular pacing is a technically feasible approach for dilated cardiomyopathy patients with refractory heart failure.
  • Preliminary results indicate significant benefits in patients with major intraventricular conduction defects.

Related Experiment Videos

  • This approach may partially correct electromechanical abnormalities.

    • Impact:

    • Biventricular pacing represents a promising new therapeutic strategy for heart failure management.
    • Controlled, randomized trials are essential to validate these encouraging preliminary findings.
    • This could lead to improved treatment outcomes for patients with advanced heart failure.